These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1050 related items for PubMed ID: 28054319

  • 1. Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer.
    Valentino A, Reclusa P, Sirera R, Giallombardo M, Camps C, Pauwels P, Crispi S, Rolfo C.
    Clin Transl Oncol; 2017 Jun; 19(6):651-657. PubMed ID: 28054319
    [Abstract] [Full Text] [Related]

  • 2. Exosomal miRNAs as novel cancer biomarkers: Challenges and opportunities.
    Salehi M, Sharifi M.
    J Cell Physiol; 2018 Sep; 233(9):6370-6380. PubMed ID: 29323722
    [Abstract] [Full Text] [Related]

  • 3. Exosomal microRNAs as liquid biopsy biomarkers in prostate cancer.
    Wang J, Ni J, Beretov J, Thompson J, Graham P, Li Y.
    Crit Rev Oncol Hematol; 2020 Jan; 145():102860. PubMed ID: 31874447
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic review.
    Endzeliņš E, Melne V, Kalniņa Z, Lietuvietis V, Riekstiņa U, Llorente A, Linē A.
    Mol Cancer; 2016 May 18; 15(1):41. PubMed ID: 27189160
    [Abstract] [Full Text] [Related]

  • 5. Detection of exosome miRNAs using molecular beacons for diagnosing prostate cancer.
    Lee J, Kwon MH, Kim JA, Rhee WJ.
    Artif Cells Nanomed Biotechnol; 2018 May 18; 46(sup3):S52-S63. PubMed ID: 30033809
    [Abstract] [Full Text] [Related]

  • 6. Exosomal and Non-Exosomal Urinary miRNAs in Prostate Cancer Detection and Prognosis.
    Foj L, Ferrer F, Serra M, Arévalo A, Gavagnach M, Giménez N, Filella X.
    Prostate; 2017 May 18; 77(6):573-583. PubMed ID: 27990656
    [Abstract] [Full Text] [Related]

  • 7. Tumor-Derived Exosomal Long Noncoding RNAs as Promising Diagnostic Biomarkers for Prostate Cancer.
    Wang YH, Ji J, Wang BC, Chen H, Yang ZH, Wang K, Luo CL, Zhang WW, Wang FB, Zhang XL.
    Cell Physiol Biochem; 2018 May 18; 46(2):532-545. PubMed ID: 29614511
    [Abstract] [Full Text] [Related]

  • 8. Simultaneous multiplexed detection of exosomal microRNAs and surface proteins for prostate cancer diagnosis.
    Cho S, Yang HC, Rhee WJ.
    Biosens Bioelectron; 2019 Dec 15; 146():111749. PubMed ID: 31600625
    [Abstract] [Full Text] [Related]

  • 9. Urinary biomarkers of prostate cancer.
    Fujita K, Nonomura N.
    Int J Urol; 2018 Sep 15; 25(9):770-779. PubMed ID: 30129068
    [Abstract] [Full Text] [Related]

  • 10. Liquid biopsy: Exosomal microRNAs as novel diagnostic and prognostic biomarkers in cancer.
    Preethi KA, Selvakumar SC, Ross K, Jayaraman S, Tusubira D, Sekar D.
    Mol Cancer; 2022 Feb 16; 21(1):54. PubMed ID: 35172817
    [Abstract] [Full Text] [Related]

  • 11. Lectin-induced agglutination method of urinary exosomes isolation followed by mi-RNA analysis: Application for prostate cancer diagnostic.
    Samsonov R, Shtam T, Burdakov V, Glotov A, Tsyrlina E, Berstein L, Nosov A, Evtushenko V, Filatov M, Malek A.
    Prostate; 2016 Jan 16; 76(1):68-79. PubMed ID: 26417675
    [Abstract] [Full Text] [Related]

  • 12. Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal Biomarkers.
    Filella X, Foj L.
    Int J Mol Sci; 2016 Oct 26; 17(11):. PubMed ID: 27792187
    [Abstract] [Full Text] [Related]

  • 13. Exosomal noncoding RNAs in prostate cancer.
    Movahedpour A, Khatami SH, Karami N, Vakili O, Naeli P, Jamali Z, Shabaninejad Z, Tazik K, Behrouj H, Ghasemi H.
    Clin Chim Acta; 2022 Dec 01; 537():127-132. PubMed ID: 36330945
    [Abstract] [Full Text] [Related]

  • 14. The clinical relevance of circulating, exosomal miRNAs as biomarkers for cancer.
    Schwarzenbach H.
    Expert Rev Mol Diagn; 2015 Dec 01; 15(9):1159-69. PubMed ID: 26202667
    [Abstract] [Full Text] [Related]

  • 15. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
    Liu Q, Yu Z, Yuan S, Xie W, Li C, Hu Z, Xiang Y, Wu N, Wu L, Bai L, Li Y.
    Oncotarget; 2017 Feb 21; 8(8):13048-13058. PubMed ID: 28055956
    [Abstract] [Full Text] [Related]

  • 16. Exosomal miRNAs-a diagnostic biomarker acting as a guiding light in the diagnosis of prostate cancer.
    Chowdhury SG, Ray R, Karmakar P.
    Funct Integr Genomics; 2022 Dec 27; 23(1):23. PubMed ID: 36574059
    [Abstract] [Full Text] [Related]

  • 17. An optimized procedure for exosome isolation and analysis using serum samples: Application to cancer biomarker discovery.
    Li M, Rai AJ, DeCastro GJ, Zeringer E, Barta T, Magdaleno S, Setterquist R, Vlassov AV.
    Methods; 2015 Oct 01; 87():26-30. PubMed ID: 25814440
    [Abstract] [Full Text] [Related]

  • 18. Hydrogel-based hybridization chain reaction (HCR) for detection of urinary exosomal miRNAs as a diagnostic tool of prostate cancer.
    Kim J, Shim JS, Han BH, Kim HJ, Park J, Cho IJ, Kang SG, Kang JY, Bong KW, Choi N.
    Biosens Bioelectron; 2021 Nov 15; 192():113504. PubMed ID: 34298498
    [Abstract] [Full Text] [Related]

  • 19. Exosome-encapsulated microRNAs as circulating biomarkers for breast cancer.
    Joyce DP, Kerin MJ, Dwyer RM.
    Int J Cancer; 2016 Oct 01; 139(7):1443-8. PubMed ID: 27170104
    [Abstract] [Full Text] [Related]

  • 20. Exosomal microRNA: a novel biomarker for breast cancer.
    He Y, Deng F, Yang S, Wang D, Chen X, Zhong S, Zhao J, Tang J.
    Biomark Med; 2018 Feb 01; 12(2):177-188. PubMed ID: 29151358
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.